Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286–287:18–24.
Cardoso R, Guo F, Heisser T, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: a population-based study in 9 countries. Lancet Reg Health Eur. 2022;21:100458.
PubMed PubMed Central Google Scholar
Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81–94.
Gilson P, Merlin JL, Harlé A. Deciphering tumour heterogeneity: from tissue to liquid biopsy. Cancers. 2022;14:1384.
PubMed PubMed Central Google Scholar
Pavlič A, Urh K, Boštjančič E, et al. Analyzing the invasive front of colorectal cancer—by punching tissue block or laser capture microdissection? Pathol Res Pract. 2023;248:154727.
Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19:12.
CAS PubMed PubMed Central Google Scholar
Pareek G, Kundu M. Physiological functions of ULK1/2. J Mol Biol. 2024;436:168472.
Demeter A, Romero-Mulero MC, Csabai L, et al. ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins. Sci Rep. 2020;10:10940.
CAS PubMed PubMed Central Google Scholar
Choi EJ, Lee JH, Kim MS, et al. Intratumoral heterogeneity of somatic mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in colon cancers. Pathol Oncol Res. 2018;24:827–32.
Yan F, Zhang X, Tan R, et al. Autophagic flux in cancer cells at the invasive front in the tumor-stroma border. Aging. 2021;13:20229–45.
CAS PubMed PubMed Central Google Scholar
Sedlak JC, Yilmaz ÖH, Roper J. Metabolism and colorectal cancer. Annu Rev Pathol. 2023;18:467–92.
Chen J, Huang Z, Chen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38.
CAS PubMed PubMed Central Google Scholar
Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37:289–92.
PubMed PubMed Central Google Scholar
Payen VL, Mina E, Van Hée VF, et al. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48–66.
Pérez-Tomás R, Pérez-Guillén I. Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers. 2020;12:3244.
PubMed PubMed Central Google Scholar
Lugli A, Zlobec I. The battle for prognosis at the invasive front of colorectal cancer. EBioMedicine. 2020;58:102918.
PubMed PubMed Central Google Scholar
Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162–80.
CAS PubMed PubMed Central Google Scholar
Li TY, Sun Y, Liang Y, et al. ULK1/2 constitute a bifurcate node controlling glucose metabolic fluxes in addition to autophagy. Mol Cell. 2016;62:359–70.
Russell RC, Guan KL. The multifaceted role of autophagy in cancer. Embo J. 2022;41:e110031.
CAS PubMed PubMed Central Google Scholar
Motoo I, Nanjo S, Ando T, et al. Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers. Gastric Cancer. 2022;25:325–35.
Gaiani F, Marchesi F, Negri F, et al. Heterogeneity of colorectal cancer progression: molecular gas and brakes. Int J Mol Sci. 2021;22:5246.
CAS PubMed PubMed Central Google Scholar
Zhong X, He X, Wang Y, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15:160.
PubMed PubMed Central Google Scholar
Long L, Xiong W, Lin F, et al. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery. J Exp Clin Cancer Res. 2023;42:117.
CAS PubMed PubMed Central Google Scholar
Zhao M, Huang C, Yang L, et al. SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma. Cell Death Dis. 2023;14:666.
CAS PubMed PubMed Central Google Scholar
Blanchard Z, Brown EA, Ghazaryan A, et al. PDX models for functional precision oncology and discovery science. Nat Rev Cancer. 2025;25:153–66.
Forero-Quintero LS, Ames S, Schneider HP, et al. Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70. J Biol Chem. 2019;294:593–607.
Chen S, Xu Y, Zhuo W, et al. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett. 2024;590:216837.
Chatterjee N, Pulipaka B, Subbalakshmi AR, et al. Unraveling the dangerous duet between cancer cell plasticity and drug resistance. Comput Syst Oncol. 2023;3:e1051.
Goldberg FW, Kettle JG, Lamont GM, et al. Discovery of clinical candidate AZD0095, a selective inhibitor of monocarboxylate transporter 4 (MCT4) for oncology. J Med Chem. 2023;66:384–97.
Comments (0)